{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:17:11Z","timestamp":1790752631146,"version":"4.1.0"},"reference-count":38,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Liver Dis"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Intrahepatic cholestasis of pregnancy (ICP) is a common disorder in the second half of pregnancy characterized by pruritus and elevated serum bile acids (BAs) with spontaneous resolution after delivery. ICP carries a risk of adverse effects on the fetus which correlates with the degree of BA elevation. ICP occurs in genetically susceptible women as the reproductive hormones increase during pregnancy. Ursodeoxycholic acid is still considered the first-line treatment for ICP though it is of unproven benefit in preventing adverse effects on the fetus. Fetal complications, such as stillbirth, increase with gestational age, so preterm delivery is generally performed in cases of severe ICP, defined as BA levels above 40\u2009\u03bcmol\/L. ICP may recur in future pregnancies and is associated with an increased risk for future hepatobiliary, immune mediated, and cardiovascular diseases. Children born of mothers with ICP have normal development but may have a risk for subsequent metabolic disease.<\/jats:p>","DOI":"10.1055\/s-0040-1722264","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T23:51:46Z","timestamp":1611186706000},"page":"103-108","source":"Crossref","is-referenced-by-count":26,"title":["Intrahepatic Cholestasis of Pregnancy: Natural History and Current Management"],"prefix":"10.1055","volume":"41","author":[{"given":"Rebecca","family":"Roediger","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaquelyn","family":"Fleckenstein","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Washington University School of Medicine, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2021,1,20]]},"reference":[{"issue":"02","key":"ref1","doi-asserted-by":"crossref","first-page":"287.e1, 2","DOI":"10.1016\/j.cgh.2015.08.022","article-title":"The epidemiology of liver diseases unique to pregnancy in a US community: a population-based study","volume":"14","author":"A M Allen","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2019.1685965","article-title":"Perinatal death by bile acid levels in intrahepatic cholestasis of pregnancy: a systematic review","author":"D Di Mascio","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/OGX.0000000000000524","article-title":"Intrahepatic cholestasis of pregnancy: a review of diagnosis and management","volume":"73","author":"A M Wood","year":"2018","journal-title":"Obstet Gynecol Surv"},{"issue":"02","key":"ref4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/hep.20336","article-title":"Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates","volume":"40","author":"A Glantz","year":"2004","journal-title":"Hepatology"},{"issue":"17","key":"ref5","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.3748\/wjg.15.2049","article-title":"Intrahepatic cholestasis of pregnancy","volume":"15","author":"V Geenes","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"01","key":"ref6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/AOG.0000000000000346","article-title":"Intrahepatic cholestasis of pregnancy","volume":"124","author":"C Williamson","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"04","key":"ref7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.7326\/0003-4819-88-4-487","article-title":"Prevalence of intrahepatic cholestasis of pregnancy in Chile","volume":"88","author":"H Reyes","year":"1978","journal-title":"Ann Intern Med"},{"issue":"04","key":"ref8","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/hep.26444","article-title":"Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: a population-based cohort study","volume":"58","author":"H U Marschall","year":"2013","journal-title":"Hepatology"},{"issue":"07","key":"ref9","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/gut.52.7.1025","article-title":"Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy","volume":"52","author":"M Savander","year":"2003","journal-title":"Gut"},{"issue":"09","key":"ref10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/sj.jp.7211545","article-title":"The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population","volume":"26","author":"R H Lee","year":"2006","journal-title":"J Perinatol"},{"issue":"02","key":"ref11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/jmf.10.2.131.135","article-title":"Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy","volume":"10","author":"S A Laifer","year":"2001","journal-title":"J Matern Fetal Med"},{"issue":"231","key":"ref12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejogrb.2018.10.041","article-title":"Intrahepatic cholestasis of pregnancy: Review of six national and regional guidelines","volume":"231","author":"M J Bicocca","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(18)31877-4","article-title":"Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses","volume":"393","author":"C Ovadia","year":"2019","journal-title":"Lancet"},{"issue":"02","key":"ref14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jhep.2015.03.010","article-title":"Intrahepatic cholestasis of pregnancy and cancer, immune-mediated and cardiovascular diseases: a population-based cohort study","volume":"63","author":"E A Wikstr\u00f6m Shemer","year":"2015","journal-title":"J Hepatol"},{"issue":"03","key":"ref15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/cld.398","article-title":"Intrahepatic cholestasis of pregnancy: diagnosis and management","volume":"4","author":"Y Bacq","year":"2014","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"04","key":"ref16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1055\/s-0038-1667299","article-title":"ABCB4 gene aberrations in human liver disease: an evolving spectrum","volume":"38","author":"M C Reichert","year":"2018","journal-title":"Semin Liver Dis"},{"issue":"02","key":"ref17","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.aohep.2019.09.010","article-title":"ABCB4 disease: many faces of one gene deficiency","volume":"19","author":"E Sticova","year":"2020","journal-title":"Ann Hepatol"},{"issue":"02","key":"ref18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the Liver","year":"2009","journal-title":"J Hepatol"},{"issue":"02","key":"ref19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/jgh.14376","article-title":"Biliary transporter gene mutations in severe intrahepatic cholestasis of pregnancy: diagnostic and management implications","volume":"34","author":"S P Yeap","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"issue":"02","key":"ref20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.clinre.2015.12.008","article-title":"The pathophysiology of intrahepatic cholestasis of pregnancy","volume":"40","author":"P H Dixon","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(19)31270-X","article-title":"Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial","volume":"394","author":"L C Chappell","year":"2019","journal-title":"Lancet"},{"issue":"06","key":"ref22","first-page":"1084","article-title":"S-adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo-controlled study with negative results","volume":"13","author":"J Ribalta","year":"1991","journal-title":"Hepatology"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S1665-2681(19)32188-X","article-title":"Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid","volume":"1","author":"D Brites","year":"2002","journal-title":"Ann Hepatol"},{"issue":"07","key":"ref24","doi-asserted-by":"crossref","first-page":"8211","DOI":"10.1096\/fj.201900015RR","article-title":"Ursodeoxycholic acid inhibits uptake and vasoconstrictor effects of taurocholate in human placenta","volume":"33","author":"E M Lofthouse","year":"2019","journal-title":"FASEB J"},{"issue":"13","key":"ref25","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/1471-0528.15926","article-title":"Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study","volume":"126","author":"L B Manna","year":"2019","journal-title":"BJOG"},{"issue":"07","key":"ref26","first-page":"CD012546","article-title":"Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy","volume":"7","author":"C Manzotti","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"04","key":"ref27","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jhep.2014.10.041","article-title":"Autotaxin activity has a high accuracy to diagnose intrahepatic cholestasis of pregnancy","volume":"62","author":"A E Kremer","year":"2015","journal-title":"J Hepatol"},{"issue":"06","key":"ref28","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0168-8278(00)80139-7","article-title":"Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management","volume":"33","author":"F Lammert","year":"2000","journal-title":"J Hepatol"},{"issue":"08","key":"ref29","doi-asserted-by":"crossref","first-page":"e38558","DOI":"10.5812\/hepatmon.38558","article-title":"Ursodeoxycholic acid and S-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy: a meta-analysis","volume":"16","author":"Y Zhang","year":"2016","journal-title":"Hepat Mon"},{"issue":"06","key":"ref30","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1053\/j.gastro.2012.08.004","article-title":"Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis","volume":"143","author":"Y Bacq","year":"2012","journal-title":"Gastroenterology"},{"issue":"02","key":"ref31","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.gastro.2005.05.009","article-title":"Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans","volume":"129","author":"H U Marschall","year":"2005","journal-title":"Gastroenterology"},{"issue":"06","key":"ref32","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ncpgasthep0521","article-title":"Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis","volume":"3","author":"U Beuers","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"issue":"02","key":"ref33","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/bcp.12480","article-title":"Effect of ursodeoxycholic acid treatment on the altered progesterone and bile acid homeostasis in the mother-placenta-foetus trio during cholestasis of pregnancy","volume":"79","author":"M C Esti\u00fa","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"19","key":"ref34","first-page":"3770","article-title":"Ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy: a multi-centered randomized controlled trial","volume":"19","author":"L Zhang","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejogrb.2015.03.020","article-title":"Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancy","volume":"189","author":"V Geenes","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"06","key":"ref36","first-page":"CD000493","article-title":"Interventions for treating cholestasis in pregnancy","volume":"2013","author":"V Gurung","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"01","key":"ref37","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/157488411794941313","article-title":"The pharmacological management of intrahepatic cholestasis of pregnancy","volume":"6","author":"F Azzaroli","year":"2011","journal-title":"Curr Clin Pharmacol"},{"issue":"07","key":"ref38","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1471-0528.2004.00167.x","article-title":"Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group","volume":"111","author":"C Williamson","year":"2004","journal-title":"BJOG"}],"container-title":["Seminars in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0040-1722264.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T23:44:06Z","timestamp":1615419846000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0040-1722264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":38,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2021,3,10]]},"published-print":{"date-parts":[[2021,1]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0040-1722264","relation":{},"ISSN":["0272-8087","1098-8971"],"issn-type":[{"value":"0272-8087","type":"print"},{"value":"1098-8971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}